Matches in SemOpenAlex for { <https://semopenalex.org/work/W187412801> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W187412801 endingPage "11" @default.
- W187412801 startingPage "101" @default.
- W187412801 abstract "MDL 72,974A [(E)-2-(4-fluorophenethyl)-3-fluoroallylamine, hydrochloride] was designed to be a selective, mechanism-based irreversible inhibitor of monoamine oxidase type B (MAO-B). The compound is a potent, selective MAO-B inhibitor in vitro and in vivo. In vitro studies revealed an IC50 value (MAO-B) of 3.6 nM with 189-fold selectivity compared to MAO-A. In rats, profound inhibition of MAO-B was achieved after a single oral dose with an ED50 of 0.18 mg/kg; a dose 44 times this amount was required to inhibit MAO-A by 50%. Selectivity was maintained following chronic dosing. MDL 72,974A had minimal sympathomimetic effects and did not potentiate the cardiovascular effects of tyramine, even at 50 times the MAO-B inhibiting dose. This inhibitor was equally effective and well-tolerated in man. In human volunteers, potent inhibition of platelet MAO-B activity was observed at submilligram doses (ED50 = 90 micrograms) following a single oral dose. Upon multiple oral doses of 100 micrograms, as much as 80% of MAO-B could be inhibited. In phase II studies, MDL 72,974A is proving to be a useful adjunct to conventional therapy. Patients (250) with Parkinson's disease, treated once daily with either 1 or 4 mg, together with L-Dopa and a decarboxylase inhibitor (MadoparR or SinemetR), saw significant improvements in symptoms compared with those on standard therapy without the inhibitor." @default.
- W187412801 created "2016-06-24" @default.
- W187412801 creator A5008327735 @default.
- W187412801 creator A5024212921 @default.
- W187412801 creator A5050614110 @default.
- W187412801 creator A5072401200 @default.
- W187412801 creator A5081063755 @default.
- W187412801 creator A5090263372 @default.
- W187412801 date "1993-01-01" @default.
- W187412801 modified "2023-09-25" @default.
- W187412801 title "MDL 72,974A: a selective MAO-B inhibitor with potential for treatment of Parkinson's disease." @default.
- W187412801 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8294896" @default.
- W187412801 hasPublicationYear "1993" @default.
- W187412801 type Work @default.
- W187412801 sameAs 187412801 @default.
- W187412801 citedByCount "2" @default.
- W187412801 crossrefType "journal-article" @default.
- W187412801 hasAuthorship W187412801A5008327735 @default.
- W187412801 hasAuthorship W187412801A5024212921 @default.
- W187412801 hasAuthorship W187412801A5050614110 @default.
- W187412801 hasAuthorship W187412801A5072401200 @default.
- W187412801 hasAuthorship W187412801A5081063755 @default.
- W187412801 hasAuthorship W187412801A5090263372 @default.
- W187412801 hasConcept C114461151 @default.
- W187412801 hasConcept C126322002 @default.
- W187412801 hasConcept C150903083 @default.
- W187412801 hasConcept C181199279 @default.
- W187412801 hasConcept C185592680 @default.
- W187412801 hasConcept C202751555 @default.
- W187412801 hasConcept C207001950 @default.
- W187412801 hasConcept C2776024655 @default.
- W187412801 hasConcept C2776077682 @default.
- W187412801 hasConcept C2776134090 @default.
- W187412801 hasConcept C2776980637 @default.
- W187412801 hasConcept C2777056448 @default.
- W187412801 hasConcept C2777752497 @default.
- W187412801 hasConcept C2778630814 @default.
- W187412801 hasConcept C2779134260 @default.
- W187412801 hasConcept C2779734285 @default.
- W187412801 hasConcept C39398028 @default.
- W187412801 hasConcept C42533223 @default.
- W187412801 hasConcept C55493867 @default.
- W187412801 hasConcept C71924100 @default.
- W187412801 hasConcept C86803240 @default.
- W187412801 hasConcept C98274493 @default.
- W187412801 hasConceptScore W187412801C114461151 @default.
- W187412801 hasConceptScore W187412801C126322002 @default.
- W187412801 hasConceptScore W187412801C150903083 @default.
- W187412801 hasConceptScore W187412801C181199279 @default.
- W187412801 hasConceptScore W187412801C185592680 @default.
- W187412801 hasConceptScore W187412801C202751555 @default.
- W187412801 hasConceptScore W187412801C207001950 @default.
- W187412801 hasConceptScore W187412801C2776024655 @default.
- W187412801 hasConceptScore W187412801C2776077682 @default.
- W187412801 hasConceptScore W187412801C2776134090 @default.
- W187412801 hasConceptScore W187412801C2776980637 @default.
- W187412801 hasConceptScore W187412801C2777056448 @default.
- W187412801 hasConceptScore W187412801C2777752497 @default.
- W187412801 hasConceptScore W187412801C2778630814 @default.
- W187412801 hasConceptScore W187412801C2779134260 @default.
- W187412801 hasConceptScore W187412801C2779734285 @default.
- W187412801 hasConceptScore W187412801C39398028 @default.
- W187412801 hasConceptScore W187412801C42533223 @default.
- W187412801 hasConceptScore W187412801C55493867 @default.
- W187412801 hasConceptScore W187412801C71924100 @default.
- W187412801 hasConceptScore W187412801C86803240 @default.
- W187412801 hasConceptScore W187412801C98274493 @default.
- W187412801 hasLocation W1874128011 @default.
- W187412801 hasOpenAccess W187412801 @default.
- W187412801 hasPrimaryLocation W1874128011 @default.
- W187412801 hasRelatedWork W187412801 @default.
- W187412801 hasRelatedWork W1972949677 @default.
- W187412801 hasRelatedWork W1983232551 @default.
- W187412801 hasRelatedWork W1983598243 @default.
- W187412801 hasRelatedWork W2016743021 @default.
- W187412801 hasRelatedWork W2026621968 @default.
- W187412801 hasRelatedWork W2062663500 @default.
- W187412801 hasRelatedWork W2081441893 @default.
- W187412801 hasRelatedWork W4224121502 @default.
- W187412801 hasRelatedWork W980740714 @default.
- W187412801 hasVolume "40" @default.
- W187412801 isParatext "false" @default.
- W187412801 isRetracted "false" @default.
- W187412801 magId "187412801" @default.
- W187412801 workType "article" @default.